long record of safety and are unlikely to cause such problems. He also offers an unusually insightful and biochemically diverse understanding of the antioxidant versus conventional therapy debate that has been raging for years. The very different redox situations of tumors and normal tissues and the balance of prosurvival and proapoptotic signaling of NF-kappaB and tumor necrosis factor appear to provide points where antioxidant and anti-inflammatory botanicals may result in therapeutic gain. Sagar's article is followed by a commentary by Brian Lawenda. We hope that these articles will contribute to refining and redirecting the antioxidant controversy with a new series of mechanistic understandings of the effects of antioxidant natural products on cancer treatments.
Jen-Hwey Chiu and colleagues explored the use of traditional Chinese medicine (TCM) by prostate cancer patients in Taiwan. The National Health Insurance Scheme in Taiwan provides coverage for TCM on an outpatient basis; patients visit either private TCM clinics or hospitals that have TCM departments for covered care. Chiu's group analyzed records from the National Health Insurance database to determine patterns of usage and practice among nearly 600 prostate cancer patients who used TCM, to provide a fascinating profile of how patients employ this medical system as a complement to their conventional treatment.
Jae Jin Lee and Jung Joo Lee discuss a small trial of Astragali Radix and other herbs for cancer-associated cachexia and anorexia. These conditions are troublesome and relevant for many patients, and it is interesting to see even preliminary data on use of herbal decoctions based on TCM. Analysis of effects of the herbal decoction on cytokines is an interesting feature of this study.
Amrollah Ahmadi and colleagues offer an observational study of advanced cancer patients taking an herbal-marine preparation as a supportive medication. One of the relevant observations from this study is an improvement in Karnofsky scores. The authors suggest that trace elements in the experimental preparation may contribute to improvements in the nutritional status of patients.
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Turmeric, Curcuma longa, has been the subject of much intriguing research in the past decade. Other species in the genus Curcuma have received much less attention. Curcuma wenujin is one of several species in China that have been used in the treatment of cervical cancer. The findings of Chuan-Bian Lim and colleagues on the significant antiproliferative and proapoptotic effects of this species suggest that broader analysis of the diverse species included in this genus would certainly repay the needed scientific investment.
Qingyihuaji formula is composed of Hedyotidis Herba, Amorphophallus Konjac, Herba Scutelleriae Barbatae, Coix Seed, Akebia Stem, Fiveleaf Gynostemma-Herb, and Java Amomum Fruit and has been used in China for treatment of pancreatic cancer. Lu-Ming Liu and colleagues questioned which genes might be downregulated when Qingyihuaji was used in cancer treatment, and they found that Ski was one of the genes affected. In the study presented in this issue, they used an innovative experimental design involving construction of tumor cell lines with and without Ski expression. In vivo and in vitro studies then revealed that Ski was indeed critical to the effect of Qingyihuaji on cancer growth. They suggest that one of the reasons that lack of, or variable, efficacy is observed for herbal formulas in the clinic is that tumors in some patients may lack the genetic mutations targeted by a particular formula, rendering them essentially resistant to use of that formula. This reasoning is certainly used in the application of new molecular target drugs, but it has not been so frequently employed with herbal formulas until the present.
In keeping with our interest in publishing articles on more intriguing and cutting-edge conventional therapies, we include in this issue a short report on the use of radioactive iodine from Jumie Wang and colleagues. 125 I may be useful in brachytherapy, a treatment method used for prostate cancer. These investigators explore the radiobiological mechanisms that may be operative with 125 I treatment.
Vitamin E is well known to be not a single substancea-tocopherol is what would usually be cited-but rather a group of 8 separate compounds, the tocopherols and the tocotrienols. Lean Teik Ng and Shu-Jing Wu explore the impact of both tocotrienols and a-tocopherol on the cell cycle signaling pathways of HeLa cells. Their results remind us of the importance and more meaningful clinical value of using complex natural substances instead of single extracted phytochemicals in our study of natural cancer treatments.
Plants in the genus Physalis are often called "groundcherries." The genus has a number of species worldwide, including the Cape Gooseberry, P peruviana, and the Cut-leaved ground-cherry, P angulata. The tomatillo, P philadelphica, is another commercial food plant. Both the Cape Gooseberry and the Cut-leaved ground-cherry have been previously noted to induce apoptosis, and they are known to have anticancer compounds. In this issue, Shaida Sulaiman and colleagues present data on the Pygmy groundcherry, P minima, and its effect on apoptosis in breast cancer. Exploring the global diversity of plant food species for anticancer effects is a sound strategy for discovering new agents that will likely be of less toxicity than many currently used drugs.
The use of photodynamic therapy, in which light is used to activate molecules with anticancer properties, has received attention in research and clinical applications. A newer type of molecule can be activated by ultrasound as well as light. This is referred to as a dual-activation therapeutic agent. Thomas Lewis presents data from in vivo testing of 2 such agents in zebra fish, establishing basic data on safety and theoretical mechanisms for effect of the agents.
The extracellular calcium-sensing receptor appears to be critical for differentiation of colonic epithelial cells, and although calcium has consequently been of great interest in colon cancer prevention, trace minerals also upregulate this receptor and may thus be of equal interest. Muhammed Aslam and colleagues present data on an extract of mineralized red algae "skeletons" that are harvested from the ocean floor and used commercially as a calcium and trace mineral source: it contains 72 types of trace minerals. Their interesting observations on the use of this natural product in a model of mice eating a high-fat "Western" type of diet, which results in colon polyps and hyperplasia, suggest that such mineral-containing products may offer an interesting approach to cancer prevention.
We continue to believe that well-documented case studies of integrative therapies are one of the bases of future scientific work, and we thus present in this issue a study of an extract of Rhus verniciflua, the lacquer tree, used in Korea for cancer treatment. The case, submitted by Seong Ha Cheon, concerns a de-allergenized preparation and its use in recurrent hepatocellular carcinoma refractory to doxorubicin and postliver transplant. For this situation there is no clear conventional therapy, and use of herbal medicines, such as those noted in this case report, may provide a treatment with low toxicity that may provide some benefit.
Finally, the issue closes with a commentary article by Jeremy Geffen, one of the leading proponents of integrative cancer therapy in the United States. This article is of particular interest for its historical overview of the development of this field in the United States and the different social influences that have molded its current manifestations. We publish general articles of this type infrequently, but with the beginning of a new decade, it seems a particularly apt time to look back over the past as well as ahead to the future of our burgeoning field.
